Clinical trial
Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta
NCT04082507 is registered in ClinicalTrials.gov with rasha medhat abdul-hady as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta
- Lead sponsor
- rasha medhat abdul-hady
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2017
- Completion date
- August 30, 2019
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.